105 related articles for article (PubMed ID: 12584267)
1. Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice.
Quaschning T; Koçak S; Bauer C; Neumayer HH; Galle J; Hocher B
Nephrol Dial Transplant; 2003 Mar; 18(3):479-83. PubMed ID: 12584267
[TBL] [Abstract][Full Text] [Related]
2. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet.
Giardina JB; Green GM; Rinewalt AN; Granger JP; Khalil RA
Hypertension; 2001 Feb; 37(2 Pt 2):516-23. PubMed ID: 11230328
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene.
Arnet UA; Novosel D; Barton M; Noll G; Ganten D; Lüscher TF
Endothelium; 1999; 6(3):175-84. PubMed ID: 10365769
[TBL] [Abstract][Full Text] [Related]
5. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia.
MacLean MR; McCulloch KM
Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030
[TBL] [Abstract][Full Text] [Related]
6. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
[TBL] [Abstract][Full Text] [Related]
7. Lack of iNOS impairs endothelial function in endothelin-1 transgenic mice.
Quaschning T; Voss F; Herzfeld S; Relle K; Kalk P; Godes M; Pfab T; Kraemer-Guth A; Bonz AW; Theuring F; Galle J; Hocher B
Kidney Blood Press Res; 2008; 31(2):127-34. PubMed ID: 18391571
[TBL] [Abstract][Full Text] [Related]
8. In-vivo interaction of nitric oxide and endothelin.
Hocher B; Schwarz A; Slowinski T; Bachmann S; Pfeilschifter J; Neumayer HH; Bauer C
J Hypertens; 2004 Jan; 22(1):111-9. PubMed ID: 15106802
[TBL] [Abstract][Full Text] [Related]
9. Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice.
d'Uscio LV; Barton M; Shaw S; Lüscher TF
Cardiovasc Res; 2002 Feb; 53(2):487-95. PubMed ID: 11827700
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
Quaschning T; Ruschitzka F; Stallmach T; Shaw S; Morawietz H; Goettsch W; Hermann M; Slowinski T; Theuring F; Hocher B; Lüscher TF; Gassmann M
FASEB J; 2003 Feb; 17(2):259-61. PubMed ID: 12490547
[TBL] [Abstract][Full Text] [Related]
11. Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.
Sachidanandam K; Harris A; Hutchinson J; Ergul A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1016-21. PubMed ID: 16741041
[TBL] [Abstract][Full Text] [Related]
12. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.
Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL
J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pump.
Schuh K; Quaschning T; Knauer S; Hu K; Kocak S; Roethlein N; Neyses L
J Biol Chem; 2003 Oct; 278(42):41246-52. PubMed ID: 12900399
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat.
Douglas SA; Hiley CR
Br J Pharmacol; 1991 Oct; 104(2):311-20. PubMed ID: 1797300
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
Quaschning T; Ruschitzka F; Shaw S; Lüscher TF
Hypertension; 2001 Feb; 37(2 Pt 2):801-5. PubMed ID: 11230376
[TBL] [Abstract][Full Text] [Related]
16. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.
Barton M; d'Uscio LV; Shaw S; Meyer P; Moreau P; Lüscher TF
Hypertension; 1998 Jan; 31(1 Pt 2):499-504. PubMed ID: 9453352
[TBL] [Abstract][Full Text] [Related]
17. Effect of radiographic contrast media on endothelium derived nitric oxide-dependent renal vasodilatation.
Morcos SK; Oldroyd S; Haylor J
Br J Radiol; 1997 Feb; 70():154-9. PubMed ID: 9135441
[TBL] [Abstract][Full Text] [Related]
18. Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide.
Traupe T; Nett PC; Frank B; Tornillo L; Hofmann-Lehmann R; Terracciano LM; Barton M
Eur J Pharmacol; 2007 Feb; 557(2-3):161-7. PubMed ID: 17182032
[TBL] [Abstract][Full Text] [Related]
19. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats.
Heygate KM; Lawrence IG; Bennett MA; Thurston H
Br J Pharmacol; 1995 Dec; 116(8):3251-9. PubMed ID: 8719804
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.
Douglas SA; Hiley CR
Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]